By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Covance Inc. 

210 Carnegie Center

Princeton  New Jersey  08540-6233  U.S.A.
Phone: 888-COVANCE Fax: 609-452-9375


SEARCH JOBS

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.3 billion, global operations in more than 20 countries, and more than 8,100 employees worldwide.

Driven by a commitment to scientific, operational and service excellence, we help sponsors accomplish all of their drug development goals, including:

  • Proving early safety
  • Conducting first-in-human studies
  • Conducting proof-of-concept studies
  • Proving safety and efficacy
  • Filing for marketing approval
  • Launching and marketing a drug
  • Ensuring patient safety and access
  • Managing risk

    We focus on meeting sponsors' timelines, delivering high-quality error-free data and providing exceptional customer service to successfully advance their compounds through the drug development continuum - as safely, efficiently and cost-effectively as possible.

    MAJOR SERVICES AND MARKETS SERVED:
    Worldwide, Covance provides the following drug development services to pharmaceutical and biotechnology companies of all sizes:

  • Research Products
  • Antibody Services
  • Biomarker Services
  • Nonclinical Development Services
  • Clinical Pharmacology Services
  • Cardiac Safety Services
  • Central Laboratory Services
  • Virtual Central Laboratory Services
  • Clinical Development Services
  • Risk Management Services
  • Commercialization Services
  • Outcomes & Consulting Services

    Locations:
    Indianapolis – 8211 SciCor Dr / Indianapolis, IN 46214
    Greenfield - 671 South Meridian Rd/ Greenfield, IN 46140
    Madison - 3301 Kinsman Blvd./Madison, WI 53704


    Key Statistics


    Email: info@covance.com
    Ownership: Public

    Web Site: Covance Inc.
    Employees: 8,100
    Symbol: CVD
     



  • Industry
    Services






    Company News
    Covance Inc. (CVD) Invites You To Join The Webcast Of Its Second Quarter 2014 Financial Results Conference Call 7/30/2014 9:12:24 AM
    Covance Inc. (CVD) Reports Second Quarter Net Revenue Growth Of 8.0% To $639 Million, Pro Forma EPS Growth Of 21.5% To $0.95 And Adjusted Net Orders Of $773 Million 7/30/2014 8:49:04 AM
    Covance Inc. (CVD) Increases Its Medical And Scientific Leadership With Two Senior-Level Appointments 7/9/2014 10:47:52 AM
    Covance Inc. (CVD) Invites You To Join The Webcast Of Its Second Quarter 2014 Financial Results Conference Call 6/25/2014 10:26:08 AM
    Covance Inc. (CVD) MarketPlace, A New Solution To Expedite Biopharmaceutical Development 6/23/2014 9:48:02 AM
    Covance Inc. (CVD) To Present At The Goldman, Sachs & Co. 35th Annual Global Healthcare Conference 6/9/2014 10:05:34 AM
    Covance Inc. (CVD) To Present At The Jefferies and Co. 2014 Global Healthcare 6/2/2014 6:43:05 AM
    Covance Inc. (CVD) Acquires Medaxial 5/19/2014 10:20:23 AM
    Covance Inc. (CVD) To Present At The UBS Global Healthcare Conference 5/19/2014 6:13:39 AM
    Covance Inc. (CVD) To Present At The Bank of America (BAC) Merrill Lynch Health Care Conference 5/13/2014 6:21:49 AM
    12345678910...
    //-->